1e
19
1
49
2
2
18
1b
1d
18
35
25
28
1d
2 29
1d
25
Eleanor S. Pollak, M.D.
78
25
28
ba
3
4
1
b
Director, Coagulation Laboratory, Department of Pathology and Laboratory Medicine, Philadelphia VA Medical Center, Philadelphia, PA
11
1d
46
Contact information
4b
4
3
3
1d
4b
310B Abramson Research Center
3a 3615 Civic Center Blvd.
Philadelphia, PA 19104
26
3a 3615 Civic Center Blvd.
Philadelphia, PA 19104
30
Office: (215) 590-6117
34 Fax: (215) 590-2320
24
93
34 Fax: (215) 590-2320
24
Email:
pollak@mail.med.upenn.edu
12
pollak@mail.med.upenn.edu
18
Publications
23 a
3
2
29
23 a
Links
da Search PubMed for articles
95 Pathology and Laboratory Medicine faculty
91 Cardiovascular Institute member profile
ba University of Pennsylvania Medical Center faculty description
c
4
b
1f
da Search PubMed for articles
95 Pathology and Laboratory Medicine faculty
91 Cardiovascular Institute member profile
ba University of Pennsylvania Medical Center faculty description
c
13
Education:
21 9 A.B. 21 (Biochemical Sciences) c
2b Harvard University, 1985.
21 9 M.D. 15 (Medicine) c
3c Yale University, School of Medicine, 1991.
c
3
3
3
3
8b
Permanent link21 9 A.B. 21 (Biochemical Sciences) c
2b Harvard University, 1985.
21 9 M.D. 15 (Medicine) c
3c Yale University, School of Medicine, 1991.
c
2 29
21
1e
1d
24
5e
65
62
e 29
27
Description of Research Expertise
24 Coagulation Proteins65
Description of Clinical Expertise
4f Clinical Coagulation, Hypercoagulability, Factor VII deficiency62
Description of Other Expertise
2a Transcriptional Regulatione 29
23
178 Cuker, A., Ptashkin B., Konkle, B.A., Pipe, S.W., Whinna, H.C., Zheng, X.L., Cines, D.B., Pollak, E.S.: Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time. Journal of Thrombosis & Haemostasis 7(1): 80-6, 2009.
18b Cucchiara, B., Messe, S.R., Mackenzie, L.M., Sansing, L., Pollak, E.S., Taylor, R.A., Shah, Q., Pacell, J.P., Kasner, S. : D-dimer, MRI DWI, and ABCD2 score for TIA risk stratification. Journal of Stroke and Cerebrovascular Diseases. In Press. Journal of Stroke and Cerebrovascular Diseases 18(5):367-73(5): 367-73, 2009.
b0 Shelat, S.G., Tomaski, A., Pollak, E.S.: Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia. 5d Clinical and Applied Thrombosis/Hemostasis 14(4): 410-4, Oct 2008.
14a Wang, Y., Kurichi, J.E., Blumenthal, N.P., Ahya, V.N., Christie, J.D., Pochettino, A., Kaiser, L.R., Sonnad, S.S., Pollak, E.S.: Multiple variables affecting blood usage in lung transplantation. Journal of Heart and Lung Transplantation 25: 533-8, 2006.
116 Pollak, E.S., Tidd, T.M., Ptashkin, B., Smith-Whitley, K., Camire, R. M., Bauer, K.A.: Asymptomatic factor VII deficiency in African Americans. American Journal of Clinical Pathology 126(1): 128-132, 2006.
15b Niiya, M., Uemura, M., Zheng, X.W., Pollak, E.S., Dockal, M., Scheiflinger, F., Wells, R.G., Zheng, X.L.: Increased ADAMTS13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo. Journal of Thrombosis and Haemostasis 4(5): 1063-1070, 2006.
123 Cucchiara, B., Messe S., Taylor R., Clarke J., Pollak, E.: Utility of D-dimer in the diagnosis of cerebral venous sinus thrombosis [letter] Journal of Thrombosis and Haemostasis. Blackwell Synergy, 3(2): 387-389, 2005.
eb Knoblauch, R., Pollak, E.S., and Russell, J.E.: Toxicity of argatroban overdose in a 65-year old man [letter] American Journal of Hematology 79(3): 248-249, 2005.
2c
7
1d
1f
Selected Publications
172 Zheng, X-W., Kudaravalli, R., Russell, T.T., DiMichele D.M., Gibb, C., Russell, J.E., Margaritis, P., Pollak, E.S.: Mutation in the factor VII hepatocyte nuclear factor 4α-binding site contributes to factor VII deficiency. Blood Coagul Fibrinolysis. Blood Coagul Fibrinolysis, 22(7): 624-7, 2011.178 Cuker, A., Ptashkin B., Konkle, B.A., Pipe, S.W., Whinna, H.C., Zheng, X.L., Cines, D.B., Pollak, E.S.: Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time. Journal of Thrombosis & Haemostasis 7(1): 80-6, 2009.
18b Cucchiara, B., Messe, S.R., Mackenzie, L.M., Sansing, L., Pollak, E.S., Taylor, R.A., Shah, Q., Pacell, J.P., Kasner, S. : D-dimer, MRI DWI, and ABCD2 score for TIA risk stratification. Journal of Stroke and Cerebrovascular Diseases. In Press. Journal of Stroke and Cerebrovascular Diseases 18(5):367-73(5): 367-73, 2009.
b0 Shelat, S.G., Tomaski, A., Pollak, E.S.: Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia. 5d Clinical and Applied Thrombosis/Hemostasis 14(4): 410-4, Oct 2008.
14a Wang, Y., Kurichi, J.E., Blumenthal, N.P., Ahya, V.N., Christie, J.D., Pochettino, A., Kaiser, L.R., Sonnad, S.S., Pollak, E.S.: Multiple variables affecting blood usage in lung transplantation. Journal of Heart and Lung Transplantation 25: 533-8, 2006.
116 Pollak, E.S., Tidd, T.M., Ptashkin, B., Smith-Whitley, K., Camire, R. M., Bauer, K.A.: Asymptomatic factor VII deficiency in African Americans. American Journal of Clinical Pathology 126(1): 128-132, 2006.
15b Niiya, M., Uemura, M., Zheng, X.W., Pollak, E.S., Dockal, M., Scheiflinger, F., Wells, R.G., Zheng, X.L.: Increased ADAMTS13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo. Journal of Thrombosis and Haemostasis 4(5): 1063-1070, 2006.
123 Cucchiara, B., Messe S., Taylor R., Clarke J., Pollak, E.: Utility of D-dimer in the diagnosis of cerebral venous sinus thrombosis [letter] Journal of Thrombosis and Haemostasis. Blackwell Synergy, 3(2): 387-389, 2005.
eb Knoblauch, R., Pollak, E.S., and Russell, J.E.: Toxicity of argatroban overdose in a 65-year old man [letter] American Journal of Hematology 79(3): 248-249, 2005.
2c